Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer

In a personalized treatment designed for a patient with pancreatic cancer resistant to other treatments, the success of Mitomycin C (MMC) has been highlighted. This was revealed in a murine xenograft tumor model encompassing pancreatic adenocarcinoma cells extracted from the patient. The patient was...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarrete, Alicia, Armitage, Emily G, Musteanu, Monica, García, Antonia, Mastrangelo, Annalaura, Bujak, Renata, López-Casas, Pedro P, Hidalgo, Manuel, Barbas, Coral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186447/
https://www.ncbi.nlm.nih.gov/pubmed/25505613
http://dx.doi.org/10.1002/prp2.67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186447/
https://www.ncbi.nlm.nih.gov/pubmed/25505613
http://dx.doi.org/10.1002/prp2.67

Ejemplares similares